These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 9088751)
21. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections. Ormrod D; Scott LJ; Perry CM Drugs; 2000 Apr; 59(4):839-63. PubMed ID: 10804039 [TBL] [Abstract][Full Text] [Related]
22. Therapy of herpes virus infections in children. Whitley RJ Adv Exp Med Biol; 2008; 609():216-32. PubMed ID: 18193668 [TBL] [Abstract][Full Text] [Related]
23. Recent developments in herpesvirus therapy. Naesens L; De Clercq E Herpes; 2001 Mar; 8(1):12-6. PubMed ID: 11867011 [TBL] [Abstract][Full Text] [Related]
24. Prophylaxis against herpesvirus infections in transplant recipients. Ljungman P Drugs; 2001; 61(2):187-96. PubMed ID: 11270937 [TBL] [Abstract][Full Text] [Related]
25. Viral skin infections in the elderly: diagnosis and management. Bansal R; Tutrone WD; Weinberg JM Drugs Aging; 2002; 19(7):503-14. PubMed ID: 12182687 [TBL] [Abstract][Full Text] [Related]
26. Zidovudine and other reverse transcriptase inhibitors in the management of human immunodeficiency virus-related disease. Matthews SJ; Cersosimo RJ; Spivack ML Pharmacotherapy; 1991; 11(6):419-48; discussion 448-9. PubMed ID: 1722897 [TBL] [Abstract][Full Text] [Related]
27. Acyclovir treatment of herpes simplex virus infections in immunocompromised humans. An overview. Alford CA Am J Med; 1982 Jul; 73(1A):225-8. PubMed ID: 6285714 [TBL] [Abstract][Full Text] [Related]
28. Antiviral drugs in pediatrics. Balfour HH; Englund JA Am J Dis Child; 1989 Nov; 143(11):1307-16. PubMed ID: 2554721 [TBL] [Abstract][Full Text] [Related]
29. Agents for treating human immunodeficiency virus infection. Acosta EP; Fletcher CV Am J Hosp Pharm; 1994 Sep; 51(18):2251-67; quiz 2286-7. PubMed ID: 7801986 [TBL] [Abstract][Full Text] [Related]
30. [Drugs active against herpesviruses]. Fillet AM Rev Prat; 1997 Mar; 47(6):623-30. PubMed ID: 9183936 [TBL] [Abstract][Full Text] [Related]
32. New antivirals - mechanism of action and resistance development. Balzarini J; Naesens L; De Clercq E Curr Opin Microbiol; 1998 Oct; 1(5):535-46. PubMed ID: 10066527 [TBL] [Abstract][Full Text] [Related]
33. Current and potential therapies for the treatment of herpes-virus infections. Villarreal EC Prog Drug Res; 2003; 60():263-307. PubMed ID: 12790345 [TBL] [Abstract][Full Text] [Related]
35. Current and potential therapies for the treatment of herpesvirus infections. Villarreal EC Prog Drug Res; 2001; 56():77-120. PubMed ID: 11417115 [TBL] [Abstract][Full Text] [Related]
36. Herpes virus infections in immunocompromised patients: problems and therapeutic interventions. Ljungman P Ann Med; 1993 Aug; 25(4):329-33. PubMed ID: 8217097 [TBL] [Abstract][Full Text] [Related]
37. Antiviral chemotherapy and chemoprophylaxis. Dolin R Science; 1985 Mar; 227(4692):1296-303. PubMed ID: 2983421 [TBL] [Abstract][Full Text] [Related]
38. Selective anti-herpesvirus agents. De Clercq E Antivir Chem Chemother; 2013 Jan; 23(3):93-101. PubMed ID: 23343513 [TBL] [Abstract][Full Text] [Related]